# Vividion Therapeutics, Inc. — Form D

Vividion Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-11. The offering totals $4.0M, of which $3.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-04-11
- Form: D
- Accession: 0001671687-16-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $4.0M
- Amount sold: $3.5M
- Remaining: $495K
- Minimum investment: $1
- Investors: 1
- Date of first sale: 2016-03-31
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-261009

## Issuer

- Name: Vividion Therapeutics, Inc.
- CIK: 0001671687
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 5820 NANCY RIDGE DR., SAN DIEGO, CA, 92121
- Phone: (858) 345-4690

## Officers, directors & promoters (23)

| Name | Role | Location |
| --- | --- | --- |
| John K Park | Director | Palo Alto, CA |
| Kristina L Burow | Director | New York, NY |
| Kristina K Burow | Director | San Diego, CA |
| John K Clarke | Director | Walla Walla, WA |
| John K Clarke | Executive Officer | Walla Walla, WA |
| Jeffrey Hatfield | Director | San Diego, CA |
| Jeffrey Hatfield | Executive Officer | San Diego, CA |
| Patricia L Allen | Executive Officer | San Diego, CA |
| Benjamin L Cravatt | Director | San Diego, CA |
| Richard L Heyman | Director | San Diego, CA |
| Thomas E Daniel | Director | San Diego, CA |
| Thomas E Woiwode | Director | San Diego, CA |
| Jakob E Loven | Director | San Diego, CA |
| Diego K Miralles | Director | San Diego, CA |
| Diego K Miralles | Executive Officer | San Diego, CA |
| Fred K Aslan | Executive Officer | San Diego, CA |
| Benjamin K Cravatt | Director | San Diego, CA |
| Jakob K Loven | Director | San Diego, CA |
| Richard K Heyman | Director | San Diego, CA |
| Tom K Daniel | Director | San Diego, CA |
| Thomas K Woiwode | Director | San Diego, CA |
| John L Clarke | Director | St. Louis, MO |
| John K Park | Executive Officer | Palo Alto, CA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-03-02](https://search.stillhousedata.com/formd/0001841613-21-000003) | D | $135.0M | $135.0M |
| [2019-05-06](https://search.stillhousedata.com/formd/0001768185-19-000003) | D | $82.0M | $82.0M |
| [2017-01-18](https://search.stillhousedata.com/formd/0001671687-17-000001) | D | $50.5M | $20.2M |

## More

- [CIK 1671687 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1671687&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001671687-16-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.